Niacin (nicotinic acid), chemically pyridine-3-carboxylic acid (C6H5NO2), is a core contributor to vitamin B3 activity. As nutrition fortification, animal feed nutrition, and fine chemical manufacturing continue to advance, niacin is widely used both as an essential nutrient and as a stable, functionalisable small-molecule building block for pharmaceutical intermediates and industrial processes. A consistent scientific framework is therefore needed to delineate key definitions, physicochemical behaviour, biological roles, and application logic.
Keywords: Niacin; Vitamin B3; Nicotinamide; NAD+; NADP+; Niacin equivalents; Nutritional fortification; Feed additive; Pharmaceutical intermediate
I. Fundamental Concepts and Classification
1.1 Nomenclature and Conceptual Boundaries
Niacin is a well-defined chemical entity within the water-soluble vitamin family. Vitamin B3 (also referred to as vitamin PP) is a functional concept in nutrition that denotes the physiological “niacin activity” supplied mainly by two vitamers: niacin and nicotinamide. In technical writing, these terms should be distinguished precisely: niacin refers to nicotinic acid; nicotinamide refers to the amide form of nicotinic acid; vitamin B3 refers to the combined activity provided by both forms.
1.2 Key Differences Between Niacin and Nicotinamide
Niacin and nicotinamide differ in chemical form, tolerability, and typical application positioning, even though they converge into a shared cofactor metabolism network in vivo.
(1) Chemical form
Niacin is a carboxylic acid, whereas nicotinamide is the corresponding amide. The two forms are interconvertible in vivo and ultimately feed into the same NAD/NADP cofactor pool.
(2) Tolerability considerations
At higher intakes, niacin is more frequently associated with flushing and sensations of warmth, itching, or tingling, whereas nicotinamide is typically not characterised by flushing as a primary response.
(3) Application positioning
Nicotinamide is more commonly used for routine nutritional supplementation and for certain skin-related formulations. Niacin has historically been used under medical supervision for lipid management; this is a medical-use context and should not be conflated with general dietary supplementation.
1.3 Significance of Niacin Equivalents (NE)
Vitamin B3 activity is obtained not only from dietary niacin/nicotinamide but also from endogenous conversion of tryptophan. For unified intake assessment, nutrition science commonly uses niacin equivalents (NE), which map different sources of vitamin B3 activity onto a comparable scale to support dietary adequacy evaluations.
II. Physicochemical Properties and Quality-Control Considerations
2.1 Representative Physicochemical Characteristics
Niacin is typically a white crystalline or crystalline powder and is relatively stable under standard storage and handling conditions. Solubility is strongly temperature- and matrix-dependent: niacin is only slightly soluble in water at ambient temperature, but solubility increases substantially in boiling water or hot ethanol; solubility also increases in alkaline solutions due to salt formation, while niacin is essentially insoluble in non-polar solvents such as diethyl ether. Aqueous solutions are mildly acidic, consistent with its carboxylic acid functionality.
Item | Information | Item | Information |
Name | Nicotinic acid | Boiling point | 292.5 °C |
Synonyms | Pyridine-3-carboxylic acid | Density | 1.473 g/cm³ |
Molecular formula | C6H5NO2 | Appearance | White crystalline powder |
Molecular weight | 123.11 | Flash point | 130.7 °C |
CAS No. | 59-67-6 | Refractive index | 1.571 |
EINECS No. | 200-441-0 | Solubility | Soluble in boiling water, boiling ethanol, alkali hydroxide solutions, and alkali carbonate solutions; soluble in propylene glycol; insoluble in diethyl ether |
Melting point | 234–238 °C | pH of aqueous solution | Slightly acidic (pH 2.7 for a saturated solution at 20 °C) |
Applications | Feed additive; pharmaceutical intermediate | Isoelectric point | 4.23–4.25 |
Safety statements | S26; S36 | Hygroscopicity | None |
Hazard symbol | Xi | λmax | 263 nm |
Risk phrases | R36/37/38 | LD50 | 5000–7000 mg/kg |
2.2 Professional Boundaries of Stability
“Stability” should be interpreted as the absence of rapid loss or pronounced degradation under appropriate processing and storage conditions, rather than absolute invariance. Under strongly alkaline conditions, strong oxidation environments, or prolonged high-temperature exposure, decomposition and side reactions can still occur and should be addressed through risk assessment and controls.
2.3 Quality-Control Focus Areas
Quality control requirements vary markedly by application domain (food, feed, and pharmaceutical use). A tiered control strategy is therefore recommended, typically covering: assay and related substances (impurity profile), loss on drying and residue on ignition, limits for heavy metals and inorganic ions, and identity/solution characteristics. For each application grade, specifications and limits should be defined against applicable standards and regulatory expectations, informed by a clear risk and use-case boundary, to ensure safety, stability, and lot-to-lot consistency.
III. Biological Roles and Mechanistic Basis
3.1 NAD+/NADP+ Systems and Energy Metabolism
The primary physiological significance of niacin is that it serves as a precursor for biosynthesis and replenishment of NAD+ and NADP+, maintaining the capacity and turnover of cellular pyridine nucleotide cofactors. NAD+/NADP+ function as ubiquitous redox cofactors in dehydrogenase reactions spanning carbohydrate, lipid, and amino-acid metabolism, and influence metabolic flux, mitochondrial respiratory chain function, and ATP generation through regulation of reducing equivalents.
(1) NAD+ primarily supports catabolism and energy generation
In glycolysis, pyruvate oxidation, the tricarboxylic acid cycle, and fatty-acid β-oxidation, NAD+ acts as an electron acceptor and is reduced to NADH. NADH delivers reducing equivalents to the mitochondrial electron transport chain, driving oxidative phosphorylation and ATP synthesis. The NAD+/NADH ratio also modulates key dehydrogenase activities and metabolic branching.
(2) NADP+ / NADPH primarily provide anabolic reducing power
Upon reduction to NADPH, NADP+ supplies the reducing equivalents required for biosynthesis of fatty acids and cholesterol, and helps maintain glutathione- and thioredoxin-based systems in a reduced state. This supports detoxification reactions and the mitigation of oxidative stress, contributing to cellular redox homeostasis.
(3) Complementary roles form a metabolic and homeostatic scaffold
NAD+ is oriented toward substrate oxidation and energy conversion, whereas NADP+/NADPH provide reducing-power reserves for biosynthesis and antioxidant defence. Their compartmentation, enzyme coupling, and demand-driven utilisation are complementary, helping cells sustain metabolic stability under fluctuating nutrient supply and stress.
3.2 Non-Redox Pathways and Cellular Homeostasis
Beyond redox cofactor roles, NAD+ also serves as a substrate for multiple enzyme-catalysed reactions involved in signalling and post-translational modification. Accordingly, NAD+ metabolism intersects with chromatin regulation, gene-expression control, DNA damage responses, cell-cycle regulation, and inflammation/stress signalling. These effects represent coupling between metabolic supply and homeostatic regulation and are typically conditional on cell type, metabolic state, nutrient availability, damage load, and enzyme expression; technical communication should avoid overextending these relationships into deterministic single-effect claims.
(1) Substrate supply for NAD+-dependent regulatory enzymes
NAD+ is utilised by NAD+-dependent deacylation and ADP-ribosylation enzymes, which modify proteins or chromatin-associated components to alter transcriptional programs and stress-response thresholds. This can influence metabolic reprogramming and resource allocation under energy-limited conditions.
(2) Support of DNA damage responses and genome maintenance
In the context of DNA damage, NAD+-dependent reactions contribute to signalling amplification and coordination of repair processes, affecting repair efficiency and cell-fate decisions as a form of metabolic support for genome stability systems.
(3) Coupling across multiple signalling axes for stress adaptation
NAD+ metabolism can couple to mitochondrial functional state, redox signalling, calcium signalling, and inflammation-associated pathways, shaping cellular adaptation to oxidative stress, nutrient variability, and environmental stimuli. A boundary-consistent framing is “multi-pathway regulation supporting homeostasis and stress adaptation,” rather than a single guaranteed physiological outcome.
IV. Dietary Sources and Nutritional Considerations
4.1 Major Dietary Sources
Niacin is broadly distributed in foods of both animal and plant origin. Organ meats (such as liver and kidney), lean meats, fish, and poultry are strong direct sources. Legumes, nuts, and whole grains can also provide niacin activity or contribute to niacin equivalents. Milk and eggs may not be prominent sources of preformed niacin, but their tryptophan supply can contribute to niacin equivalents through endogenous conversion.
4.2 Dietary Pattern Factors
Dietary patterns and processing can materially influence effective vitamin B3 availability and assessment:
(1) Effects of grain processing
The degree of grain refining affects retention of niacin-related nutrients and other co-nutrients.
(2) Protein and tryptophan supply
Tryptophan intake influences the endogenous contribution to niacin equivalents and should be considered when assessing adequacy.
(3) B-vitamin network effects
B vitamins act as a functional group supporting metabolic networks; evaluation is best interpreted in the context of overall diet quality, energy intake, and protein supply.
V. Deficiency and Associated Health Risks
5.1 Typical Contexts for Deficiency Risk
Deficiency risk typically arises through three pathways: insufficient intake, impaired utilisation, or increased demand. Long-term monotonous diets or inadequate protein intake can reduce baseline supply; gastrointestinal malabsorption or chronic diarrhoea can reduce uptake and utilisation; and chronic catabolic states or increased physiological demand can erode nutritional safety margins, making marginal insufficiency clinically relevant.
5.2 Pellagra Spectrum and Symptom Framework
Severe deficiency can lead to pellagra, classically affecting skin, the gastrointestinal tract, and the nervous/psychiatric system. Manifestations are often non-specific; professional assessment emphasises the risk background, symptom constellation, and an integrated chain of nutritional evaluation evidence.
(1) Skin and mucosa
Symmetric dermatitis-like changes in sun-exposed areas, often aggravated by sunlight, with roughness, scaling, or hyperpigmentation; oral mucosal discomfort and glossitis-like findings may occur.
(2) Gastrointestinal system
Reduced appetite, abdominal discomfort, and diarrhoea may be observed.
(3) Nervous and neuropsychiatric system
Fatigue, reduced attention, and fluctuations in mood or sleep can occur; differential assessment should consider other nutrient deficiencies, infection, endocrine disorders, and neurological diseases.
VI. Applications and Industrial Value
6.1 Feed Additive
As a water-soluble vitamin additive, niacin is used in feed formulations to improve nutritional balance and utilisation efficiency, supporting species- and stage-specific nutrient management across livestock, poultry, and aquaculture. Formulation strategies should be set against species, production stage, basal diet composition, applicable standards/regulations, and cost models.
6.2 Food Fortification
In foods, niacin is primarily used for nutritional fortification and supplementation to reduce the risk of inadequate vitamin B3 supply associated with dietary patterns. Fortification schemes should be designed based on target population intake, the chosen food vehicle, stability boundaries in processing/storage, and applicable regulatory limits.
6.3 Pharmaceutical Intermediates and Fine Chemicals
Niacin has practical chemical versatility as a platform molecule and is used as a pharmaceutical intermediate for building diverse derivatives. In fine chemicals it can also enter process chains related to dyes, electroplating, and photosensitive materials. Because application domains differ substantially in grade, impurity controls, stability requirements, and compliance expectations, quality and risk controls should be defined on a use-case basis.
VII. Laboratory Use Considerations
7.1 Risk Identification and Compliance Documentation
Niacin is commonly classified as an irritant to the eyes, skin, and respiratory tract; laboratory management should follow supplier SDS documentation, institutional EHS policies, and local regulatory requirements. For operations involving high temperature, strong alkali, strong oxidants, or scale-up, controls should be escalated in accordance with formal risk assessment outcomes.
7.2 Weighing, Transfer, and Personal Protection
(1) Dust control
Weighing and aliquoting should preferentially be performed in a fume hood to minimise airborne dust and inhalation exposure.
(2) Baseline personal protective equipment (PPE)
Standard PPE typically includes a lab coat, disposable gloves, and safety glasses; additional protection should be implemented per institutional requirements when dust or splash risks are present.
(3) Contamination control
After handling, work surfaces and tools should be decontaminated to prevent cross-contamination into analytical systems or biological assays.
7.3 Solution Preparation and pH Management
(1) Dissolution strategy
Given limited solubility in water, gentle heating can facilitate dissolution. For higher-concentration solutions, alkaline conditions may be used to promote solubility via salt formation, but downstream pH impacts on reactions or biological systems must be assessed.
(2) pH adjustment principles
Adjust pH slowly and in increments with continuous monitoring to avoid local high-alkali microenvironments that can trigger side reactions or sample degradation.
(3) Filtration and sterility requirements
For biological use, sterile filtration is generally preferred. Whether heat treatment is acceptable should be decided based on stability verification within the target system.
7.4 Storage, Compatibility, and Waste Disposal
(1) Storage
Store tightly closed in a dry environment to minimise moisture uptake and caking; keep away from strong oxidants and maintain complete labelling.
(2) Compatibility
Avoid prolonged co-exposure to strong oxidants or strong alkali, and avoid high-temperature mixed reactions without prior verification; specialised matrices should be evaluated at small scale before broader use.
(3) Waste management
Residual solutions and wash liquids should be collected and disposed of as chemical waste according to institutional classification and procedures; direct discharge is not appropriate.
(1) Prerequisites for quantitative analysis
① Define the reference standard grade, drying state, and content assignment approach.
② Establish a metrological chain for weighing, solution preparation, and transfers, with explicit uncertainty control points.
(2) Method and stability verification
① Implement blanks, spike recovery, and assessments of linearity and precision.
② Conduct stability studies to control systematic error from moisture uptake, pH drift, or container adsorption.
(3) Traceability and consistency management
① Record lot number, storage conditions, and opening date.
② For cross-lot or cross-project use, maintain deviation traceability and internal consistency evaluation records.
VIII. Aladdin-Related Products
Catalog No. | Product Name | CAS No. | Specifications or Purity |
Nicotinic acid | 59-67-6 | PharmPure™, USP | |
Nicotinic acid | 59-67-6 | Moligand™, for synthesis | |
Nicotinic acid | 59-67-6 | Moligand™, for cell culture, suitable for insect cell culture, ≥99% | |
Nicotinic acid | 59-67-6 | Moligand™, suitable for plant cell culture, ≥99% | |
Nicotinic acid | 59-67-6 | Moligand™, ≥99.5%(HPLC) | |
Nicotinic acid | 59-67-6 | Moligand™, ≥99% | |
Nicotinic acid | 59-67-6 | Moligand™, 10mM in DMSO |
Through NAD+/NADP+ cofactor systems, niacin supports essential metabolic processes and is widely deployed as both a fortification nutrient and a chemical platform molecule across feed, food, pharmaceutical, and fine-chemical applications. Clear conceptual boundaries, physicochemical understanding, and fit-for-purpose quality control facilitate compliant, verifiable, and traceable use across these scenarios.
Aladdin: https://www.aladdinsci.com/